Movatterモバイル変換


[0]ホーム

URL:


US9717503B2 - Electrolytic detachment for implant delivery systems - Google Patents

Electrolytic detachment for implant delivery systems
Download PDF

Info

Publication number
US9717503B2
US9717503B2US14/708,661US201514708661AUS9717503B2US 9717503 B2US9717503 B2US 9717503B2US 201514708661 AUS201514708661 AUS 201514708661AUS 9717503 B2US9717503 B2US 9717503B2
Authority
US
United States
Prior art keywords
implant
distal end
proximal end
weld joints
wire
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US14/708,661
Other versions
US20160331381A1 (en
Inventor
Jianlu Ma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LPfiledCriticalCovidien LP
Priority to US14/708,661priorityCriticalpatent/US9717503B2/en
Assigned to COVIDIEN LPreassignmentCOVIDIEN LPASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: MA, JIANLU
Priority to CA2927874Aprioritypatent/CA2927874C/en
Priority to EP16166685.4Aprioritypatent/EP3092956B1/en
Priority to JP2016090676Aprioritypatent/JP6203327B2/en
Priority to KR1020160055086Aprioritypatent/KR101788972B1/en
Priority to CN201610304068.8Aprioritypatent/CN106137294B/en
Assigned to COVIDIEN LPreassignmentCOVIDIEN LPCORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY STREET ADDRESS PREVIOUSLY RECORDED AT REEL: 037916 FRAME: 0161. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.Assignors: MA, JIANLU
Publication of US20160331381A1publicationCriticalpatent/US20160331381A1/en
Publication of US9717503B2publicationCriticalpatent/US9717503B2/en
Application grantedgrantedCritical
Activelegal-statusCriticalCurrent
Adjusted expirationlegal-statusCritical

Links

Images

Classifications

Definitions

Landscapes

Abstract

Detachment of an implant from a delivery assembly can be electrolytic. A distal end of a core member and a proximal end of an implant can be joined together by one or more weld joints disposed axially between the distal end and the proximal end, the one or more weld joints being further disposed at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end. Delivery of a detachable implant as described herein can include advancing, to a target location within a patient, an implant having a proximal end and being connected to a distal end of a core member by one or more weld joints, as described above, and separating the implant from the core member by corroding the one or more weld joints.

Description

FIELD
The subject technology relates to delivery of implantable devices by a delivery system.
BACKGROUND
The use of endovascular techniques for the implantation of medical devices for the treatment and the occlusion of body cavities such as arteries, veins, fallopian tubes or vascular deformities is known in the art. For example, occlusion of vascular aneurysms can be performed using an implantable device, such as an intrasaccular implant, that is introduced with the aid of an endovascular delivery wire through a catheter. Once moved to the treatment site, the intrasaccular implant can be moved into the aneurysm cavity to occlude the aneurysm.
The severance of the implant from the delivery wire can be problematic. On the one hand, the device must be capable of forming a small profile as possible to be guided through the fine bore of the catheter to its destination, while on the other hand it must bring about a reliable severance of the implant. Absent a reliable severance of the intrasaccular implant, withdrawal of the delivery wire and catheter may cause unintended removal of the intrasaccular implant from the cavity to be occluded and thus injure and/or rupture of the wall of the cavity or vessel.
Traditional mechanical methods for the severance of implants from the insertion means are reliable. However, the necessary rigidity of the connection between the implant and the delivery means can impede the introduction of the implant. Furthermore, the low load carrying capacity of the connection due to its rigidity entails an appreciable risk of premature detachment of the insertion means from the occluding implant. Moreover, in the case of mechanical separation of the inserting wire and the implant, mechanical energy must be transmitted (e.g., by rotation of the inserting wire), which may cause the implant to be dislodged out of the correct position.
Traditional electrolytic severance of the implant involves using an electrolytically corrodible design on the end of the delivery wire at the connection between the delivery wire and the implant. Such a device can elegantly makes use of the voltage applied to the implant serving as an anode for electrothrombosis. However, the connection of the implant to the delivery wire is limited by the requirements of the electrolytically corrodible region. For example, the only materials that can be utilized are those which have a sufficiently high degree of strength to enable reliable guidance of the implant? through the delivery wire. The selection of materials for forming the point of eventual electrolytic severance is consequently extremely limited.
In the case of traditional devices for the electrolytic severance of implants, the implant and the delivery wire are not produced integrally, but instead are produced mechanically connected to each other. This design has the inherent disadvantage that the delivery wire must be tapered toward its end in an involved grinding operation in order to ensure sufficient strength in the proximal zone of the delivery wire while facilitating electrolytic, corrosive severance of the wire at the distal part of the delivery wire connected to the implant. In order to ensure sufficient strength of the connection point, the corrodible zone of the end of the delivery wire must not have a diameter below a certain minimum value since it is subjected to a high flexural load. The corrodible wire end representing the connection point between the implant and the delivery wire can be consequently extremely rigid and require a relatively long time for electrolytic corrosive severance.
SUMMARY
Electrolytic severance of an implantable medical device can involve using an electrolytically corrodible design on the end of a delivery wire at the connection between the delivery wire and the medical device.
According to some embodiments, a delivery system can comprise: a core member having a distal end; an implant, having a proximal end; and one or more weld joints disposed axially between the distal end and the proximal end, the one or more weld joints being further disposed at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end.
The one or more weld joints can be of a material more susceptible to electrolytic corrosion than each of the distal end of the core member and the proximal end of the implant. The one or more weld joints can comprise a plurality of weld joints disposed axially between the distal end and the proximal end, the plurality of weld joints being distributed about the radially outermost periphery of the distal end and the radially outermost periphery of the proximal end. The plurality of weld joints can be evenly distributed about the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end. A radially centermost region of the distal end can be spaced apart from a radially centermost region of the proximal end by an axial gap. The distal end can connect to the proximal end only via the one or more weld joints. The one or more weld joints occupy no more than 5% of a zone (i) axially between the proximal end and the distal end and (ii) radially within the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end. At least 95% of a zone (i) axially between the proximal end and the distal end and (ii) radially within the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end can be a gap.
According to some embodiments, a method of delivering a detachable implant can comprise: advancing, to a target location within a patient, an implant having a proximal end and being connected to a distal end of a core member by one or more weld joints disposed axially between the distal end and the proximal end, the one or more weld joints being further disposed at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end; and separating the implant from the core member by corroding the one or more weld joints.
The separating of the implant from the core member can comprise electrolytically corroding the one or more weld joints. The separating of the implant from the core member can comprise applying an electrical current through the core member to the one or more weld joints while the one or more weld joints are in an electrolyte solution. During the separation, a radially centermost region of the distal end can be spaced apart from a radially centermost region of the proximal end by an axial gap. The advancing can comprise: advancing a distal end of a catheter, containing the implant, near the target location; and advancing the implant out of the distal end of the catheter and into the target location. The method can comprise withdrawing the core member.
According to some embodiments, a method of making a detachable implant can comprise: aligning, along a central axis, a distal end of a core member to be axially adjacent to a proximal end of an implant; and forming, at least partially from the proximal end and the distal end, one or more weld joints at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end.
The aligning can comprise maintaining an axial gap between the proximal end and the distal end. The forming can comprise applying a filler material that forms a portion of the one or more weld joints. The one or more weld joints can be at least partially of a material more susceptible to electrolytic corrosion than each of the distal end of the core member and the proximal end of the implant. The forming can comprise connecting the distal end to the proximal end only via the one or more weld joints (e.g., weld pool).
Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the subject technology as claimed.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this description, illustrate aspects of the subject technology and, together with the specification, serve to explain principles of the subject technology.
FIG. 1 shows a perspective view providing an overview of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 2 shows a perspective side view of a braid ball implant, in accordance with one or more embodiments of the present disclosure.
FIG. 3 shows a side-sectional view of a braid ball implant deployed within a bifurcation aneurysm, in accordance with one or more embodiments of the present disclosure.
FIG. 4 shows a side view of a distal end of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 5 shows a sectional view of a distal end of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 6 shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 7A shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 7B shows a sectional view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 8 shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 9A shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 9B shows a sectional view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 10 shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 11A shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 11B shows a sectional view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 12 shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 13A shows a side view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
FIG. 13B shows a sectional view of a detachment zone of a delivery system, in accordance with one or more embodiments of the present disclosure.
DETAILED DESCRIPTION
In the following detailed description, specific details are set forth to provide an understanding of the subject technology. It will be apparent, however, to one ordinarily skilled in the art that the subject technology may be practiced without some of these specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the subject technology.
In accordance with some embodiments disclosed herein is the realization that detachment of an implant from a delivery assembly can be improved by enhancing features to focus the electrolytic corrosion activity. Thus, various embodiments provide for detachment zones that can facilitate electrolytic detachment of a delivery mechanism, making the detachment process faster and more reliable. For example, the total cross-sectional area of the detachment zone that must be electrolytically corroded to achieve detachment can be significantly less than a total cross-sectional area of other zones adjacent to the detachment zone, thereby decreasing the amount of time required to achieve detachment. Such improved efficiency of electrolytic detachment can be achieved while maintaining significant column strength by providing multiple points of contact between sections connected at the detachment zone. The column strength of the detachment zone facilitates a user's control and/or manipulation of the implant during use of the delivery assembly and reduces incidence of inadvertent detachment.
The implant can be implanted in body cavities or blood vessels. In addition to the implant, the delivery system can comprise a voltage source, a cathode, and a catheter. The implant can be slid in the catheter in the longitudinal direction. A delivery wire may engage the implant and be adapted to serve as an anode, such that a portion of the delivery wire is designed to be electrolytically corroded at one or more points so that while in contact with a body fluid, one or more portions of the implant may be released from the delivery wire.
According to some embodiments,FIG. 1 presents an overview of adelivery system10 including animplant20 and ahandle42. Thehandle42 shown provides proximal access to adelivery wire44 that engages theimplant20 at a distal end thereof. The catheter/pusher shaft12 can include a simple extrusion (e.g., PTFE, FEP, PEEK, etc.) or can be constructed using conventional catheter construction techniques and include a liner, braid support and outer jacket (not shown). Aloading sheath48 is typically provided over the shaft of apusher12.
Apower supply46 may be coupled to a proximal portion of thedelivery wire44. Thepower supply46 may also be coupled to a proximal portion of thehandle42 or to the patient. A current can flow from thepower supply46, to a detachment zone at or near theimplant20, and to a return path via the catheter shaft12 (and/or another structure extending near the detachment zone. Alternatively, the current from the detachment zone may flow to the patient, and subsequently to ground or to thepower supply46.Power supply46, for example, may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current. A positive terminal of a direct current power supply, as shown inFIG. 1, may be coupled to the proximal portion of thedelivery wire44 and a negative terminal of a direct current power supply may be coupled to the proximal portion of thehandle42.Power supply46 may provide a current through thedelivery system10 to initiate an electrolytic process during use of the assembly in a fluid medium such as a bloodstream, which may be used as an electrolyte. A power supply, such as an alternating or direct current power supply, may additionally be used to initiate an electrothrombosis process.
According to some embodiments, as shown inFIGS. 2 and 3, animplant20 delivered by thesystem10 can be a braid ball implant. Thebraid ball implant20 can be formed from tubular braid stock including a resilient material, such as Nitinol, that defines an open volume (generally round, spherical, ovular, heart-shaped, etc.) in an uncompressed/unconstrained state. The size of the implant can be selected to fill an aneurysm2, so the proximal end53 of the device helps direct blood flow along the surface of the braid from which it is constructed to the branch vessels8. Adistal end56 of thebraid ball implant20 can be dome-shaped. Thebraid ball implant20 can include a single layer or twolayers26,28 (inner and outer layer, respectively) construction at least where impacted by flow at the neck9 of the aneurysm2. As shown, one or more turns of a coil (e.g., Pt wire) or a band (not shown) can provide a distal radiopaque feature to mark the location of theimplant20. Some exemplary implants that can be used in conjunction with the systems described herein are disclosed at U.S. Pub. No. 2013/0123830, published on May 16, 2013, the entirety of which is incorporated herein by reference.
According to some embodiments, theimplant20 can include ahub50 at a proximal end53 thereof. Thehub50 can be fixedly attached to the remainder of theimplant20. For example, thehub50 can grasp braided filaments of thelayers26,28 of theimplant20.
According to some embodiments, theimplant20 can be set within an aneurysm sac2 at avascular bifurcation4, formed bytrunk vessel6 and efferent vessels8. Theimplant20 can be delivered by access through the trunk vessel6 (e.g., the basilar artery), preferably through a commercially available microcatheter with a delivery system as detailed below. To deliver theimplant20, thepusher sleeve12 is positioned such that theimplant20 can be delivered at least partially into the aneurysm sac2. Finally, thepusher sleeve12 is withdrawn into thedelivery catheter48.
While theimplant20 can be a braid ball implant as illustrated herein, theimplant20 can have any other form or structure, according to various embodiments. For example, theimplant20 can be a vasoocclusive coil, a cylindrical, tube-like stent, or a filter. Other types of implants and treatment devices are generally known. The subject technology can be applied to any such implant or treatment device for delivery and detachment thereof. For example, a given implant can include ahub50 for engagement and release by a delivery system, as disclosed further herein.
Traditional electrolytic detachment members are generally a single wire with a constant diameter. These detach wires are generally as drawn and are very corrosion resistant due to the crystalline structure. Generally, when these detach wires are used they will leave behind small particulate and these particulate interfere with MRI imaging and also could lead to secondary stroke if particulate flows to distal vessel. Detachment time can be reduced by concentrating erosion to a limited area.
According to some embodiments, as shown inFIGS. 4 and 5, adelivery system10 includes a delivery wire31 (e.g., core member, etc.), animplant wire33, and adetachment zone30 between thedelivery wire31 and theimplant wire33. Thedetachment zone30 can represent the joining of adistal end41 of thedelivery wire31 and aproximal end43 of theimplant wire33, as best shown inFIG. 6. The types and methods of joining thedelivery wire31 and theimplant wire33 across thedetachment zone30 are discussed further herein.
According to some embodiments, portions of thedelivery wire31 can be coated with a nonconductive material. A proximal insulatinglayer34 can be provided over at least a portion of an outer surface of thedelivery wire31. For example, the proximal insulatinglayer34 can circumferentially surround an outer surface of thedelivery wire31. According to some embodiments, a distal insulatinglayer32 can be provided over at least a portion of an outer surface of theimplant wire33. For example, the distal insulatinglayer32 can circumferentially surround and contact an outer surface of theimplant wire33.
According to some embodiments, proximal and distal insulatinglayers34,32 leave exposed thedetachment zone30 between thedelivery wire31 and theimplant wire33. When in contact with a body fluid, such as blood, the fluid serves as an electrolyte allowing current to be focused on thenon-coated detachment zone30. The proximal and distal insulatinglayers34,32 prevent exposure of thedelivery wire31 andimplant wire33 to the fluid. Accordingly, electrical energy conducted along thepusher wire74 is concentrated at thedetachment zone30, thereby reducing the time required to erode away thedetachment zone30. The proximal and distal insulatinglayers34,32 can be over-molded, co-extruded, sprayed on, or dip-coated with respect to thedelivery wire31 and/or theimplant wire33.
The proximal and distal insulatinglayers34,32 can be of an electrically nonconductive or insulative polymer, such as polyimide, polypropylene, polyolefins, combinations thereof, and the like. Laser ablation can be employed to selectively remove the coating to a controlled length minimizing the time required to erode through the component. Lengths as small as 0.0005″ and as large as 0.1″ or longer can be removed. According to some embodiments, lengths ofdetachment zone30 can be greater than 0.005″ and/or less than 0.010″ to provide sufficient exposure to achieve detachment times of less than 60 seconds. Factors such as cross-sectional area, lengths, and material can be selected to regulate the detachment time to be within a desired range.
At least a portion of thedelivery wire31, theimplant wire33, and/or thedetachment zone30 can be coated with a conductive material, such as carbon, gold, platinum, tantalum, combinations thereof, and the like. One or more metallic coatings can be applied using known plating techniques.
Thedelivery wire31, theimplant wire33, and/or components of thedetachment zone30, can include one or more of the following materials: ceramic materials, plastics, base metals or alloys thereof, and preferably stainless steel. Some of the most suitable material combinations for forming the electrolytically corrodible points can include one or more of the following: stainless steels, preferably of the type AISI 301, 304, 316, or subgroups thereof; Ti or TiNi alloys; Co-based alloys; noble metals; or noble metal alloys, such as Pt, Pt metals, Pt alloys, Au alloys, or Sn alloys. Further, ceramic materials and plastics employed for forming the implant can be electrically conductive.
As shown inFIG. 5, the distal insulatinglayer32 electrically isolates theimplant20 from an electrical charge conducted along a length of thedelivery wire31 and theimplant wire33. A proximal end of the distal insulatinglayer32 may be positioned at or proximal to thehub50, and a distal end of the distal insulatinglayer32 may be positioned at or distal to thehub50. Likewise, a proximal end of theimplant wire33 may be positioned proximal to thehub50, and a distal end of theimplant wire33 may be positioned within or distal to thehub50.
According to some embodiments, as shown inFIG. 5, thedelivery wire31 can include ananchor end27 at a terminal distal end of thedelivery wire31. Theanchor end27 can be located distal to thehub50. For example, theanchor end27 can be located within an interior portion of theimplant20. Theanchor end27 can have a maximum cross-sectional dimension that is greater than an inner cross-sectional dimension of aninner band52. Accordingly, thedelivery wire31 is prevented from moving proximally entirely through theinner band52. For example, an interface between the distal insulatinglayer32 and theinner band52 or an interface between the distal insulatinglayer32 and thedelivery wire31 may allow a degree of movement of thedelivery wire31 relative to theinner band52. To prevent thedelivery wire31 from being removed distally from within theinner band52, theanchor end27 can be of a size that cannot pass entirely proximally through theinner band52.
According to some embodiments, amarker coil36 is wound helically about an outer surface of the proximal insulatinglayer34. Themarker coil36 can be of a radiopaque material, such as platinum, gold, palladium, iridium, and alloys thereof. Aninsulative layer38 can be provided about an outer surface of themarker coil36. For example, as shown inFIG. 5, theinsulative layer38 can extend over an entire length of themarker coil36 and distally beyond themarker coil36, such that every portion of themarker coil36 is covered by theinsulative layer38. A distal end of theinsulative layer38 may contact and/or be adhered to the proximal insulatinglayer34. Theinsulative layer38 can be of an insulative biocompatible polymer material, such as polytetrafluoroethylene (PTFE). Theinsulative layer38 may be shrink-wrapped over the corresponding portion of the delivery wire.
According to some embodiments, as shown inFIG. 5, apusher wire74 can be integrally connected to thedelivery wire31. Accordingly, an electric charge applied to thepusher wire74 can be conducted through thepusher wire74, thedelivery wire31, and thedetachment zone30. Furthermore, an axial force applied to thepusher wire74 can result in an axial movement of thedelivery wire31 and theimplant20.
Referring now toFIGS. 6 and 7A-7B, with continued reference toFIGS. 1-5, illustrated are various views of anexemplary detachment zone60, according to one or more embodiments of the subject technology. More particularly,FIG. 6 depicts a side view of thedelivery wire31 and theimplant wire33,FIG. 7A depicts a side view of thedetachment zone60 in a joined configuration, andFIG. 7B depicts a cross-sectional view of thedetachment zone60 in a joined configuration. Thedetachment zone60 may be similar in some respects to thedetachment zone30 ofFIGS. 4-5 and therefore may be best understood with reference thereto, where like numerals indicate like elements or components not described again in detail. Similar to thedetachment zone30 ofFIGS. 4-5, for example, thedetachment zone60 may join thedistal end41 of thedelivery wire31 to theproximal end43 of theimplant wire33.
According to some embodiments, as shown inFIG. 6, thedistal end41 of thedelivery wire31 can be brought to theproximal end43 of theimplant wire33, to provide agap70 there between. Thegap70 can be any size that facilitates application of weld joints68. For example, thegap70 can be less than the diameter of thedelivery wire31 and/or theimplant wire33. The gap can be large enough to limit or prevent stagnation of blood between thedelivery wire31 and/or theimplant wire33. By further example, thegap70 can be zero, where at least a portion of thedelivery wire31 contacts theimplant wire33.
According to some embodiments, as shown inFIG. 7A, one or more weld joints68 can be formed between thedistal end41 of thedelivery wire31 and theproximal end43 of theimplant wire33. As used herein, a weld joint refers to a structure spanning a gap to connect two structures. According to some embodiments, the weld joints68 are formed from portions (e.g., weld pools) of the respective structures extending axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33.
According to some embodiments, the weld joints68 can be formed by treating portions of thedelivery wire31 and/or theimplant wire33 to integrally combine thedelivery wire31 and/or theimplant wire33. For example, a welding device (not shown) can apply energy to thedelivery wire31 and/or theimplant wire33 at discrete locations near thegap70 so that a portion of thedelivery wire31 contacts and coalesces with a portion of theimplant wire33. The welding device can perform its function by applying a laser beam, an electron beam, a gas flame, an electric arc, friction, and/or ultrasound. Thedelivery wire31 and theimplant wire33 can coalesce at one or more weld joints68 as portions thereof are melted, contacted, and subsequently cooled. According to some embodiments, only a portion of thedelivery wire31 is treated to coalesce with a portion of theimplant wire33. According to some embodiments, only a portion of theimplant wire33 is treated to coalesce with a portion of thedelivery wire31. According to some embodiments, both a portion of thedelivery wire31 and a portion of theimplant wire33 are treated to coalesce with each other.
According to some embodiments, as shown inFIG. 7B, some or all of the weld joints68 are located at a radiallyouter periphery64 of one or both of thedelivery wire31 and theimplant wire33. A portion of one or more weld joints68 can extend radially outwardly from theouter periphery64 of one or both of thedelivery wire31 and theimplant wire33. A portion of one or more weld joints68 can extend radially inwardly from theouter periphery64 of one or both of thedelivery wire31 and theimplant wire33.
According to some embodiments, each weld joint68 can be circumferentially displaced from a circumferentially adjacent weld joint68. The weld joints68 can be distributed about a central axis with or without radial symmetry. A void or open space of thegap70 may remain between circumferentially adjacent weld joints68. A greater portion of thegap70 near theouter periphery64 may remain a void than the portion of thegap70 that is occupied by the weld joints68, each having awidth72.
According to some embodiments, a radially centermost region of thedistal end41 can remain spaced apart from a radially centermost region of theproximal end43 by an axial gap. According to some embodiments, one or more weld joints68 may also be provided at radially inward locations (not shown), such as along a central axis of thedelivery wire31 and/or theimplant wire33.FIGS. 7A-B show four weld joints68. As will be appreciated, more or fewer than four weld joints may be provided, without departing from the scope of the disclosure. For example, thedetachment zone30 may provide 1, 2, 3, 4, 5, 6, 7, 8, 9, or more weld joints68.
According to some embodiments, as shown inFIG. 7B, in a cross-section of thegap70, a total area occupied by the weld joints68 can be less than a cross-sectional area of thedelivery wire31 and/or theimplant wire33. According to some embodiments, the weld joints68 can occupy no more than 5% of a zone (i) axially between theproximal end43 and thedistal end41 and (ii) radially within the radiallyoutermost periphery64 of thedistal end41 and/or the radially outermost periphery of theproximal end43. According to some embodiments, at least 95% of this same zone can remain a void or open space.
Referring now toFIGS. 8 and 9A-9B, with continued reference toFIGS. 1-5, illustrated are various views of anexemplary detachment zone80, according to one or more embodiments of the subject technology. More particularly,FIG. 8 depicts a side view of thedelivery wire31 and theimplant wire33,FIG. 9A depicts a side view of thedetachment zone80 in a joined configuration, andFIG. 9B depicts a cross-sectional view of thedetachment zone80 in a joined configuration. Thedetachment zone80 may be similar in some respects to thedetachment zone30 ofFIGS. 4-5 and therefore may be best understood with reference thereto, where like numerals indicate like elements or components not described again in detail. Similar to thedetachment zone30 ofFIGS. 4-5, for example, thedetachment zone80 may join thedistal end41 of thedelivery wire31 to theproximal end43 of theimplant wire33.
According to some embodiments, as shown inFIGS. 6 and 8, thedistal end41 of thedelivery wire31 can be brought to theproximal end43 of theimplant wire33, to provide a gap90 there between. The gap90 can be any size that facilitates application of weld joints88. For example, the gap90 can be less than the diameter of thedelivery wire31 and/or theimplant wire33. By further example, the gap90 can be zero, where at least a portion of thedelivery wire31 contacts theimplant wire33.
According to some embodiments, as shown inFIG. 9A, one or more weld joints88 can be formed between thedistal end41 of thedelivery wire31 and theproximal end43 of theimplant wire33. According to some embodiments, the weld joints68 are filler material, other than the material of thedelivery wire31 and theimplant wire33, that extend axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33.
According to some embodiments, the weld joints88 can be formed by adding filler material between or on portions of thedelivery wire31 and portions of theimplant wire33 to bridge the gap90. For example, a welding device (not shown) can apply energy to a filler material at the gap90 so that the filler material contacts thedelivery wire31 and theimplant wire33 and coalesces into weld joints88. The welding device can perform a soldering or brazing operation. By further example, the filament material can be gold, silver, or combinations thereof. For example, the filler material may have a melting point that is lower than a melting point of thedelivery wire31 and/or theimplant wire33.
According to some embodiments, as shown inFIG. 9B, some or all of the weld joints88 are located at a radially outer periphery84 of one or both of thedelivery wire31 and theimplant wire33. A portion of one or more weld joints88 can extend radially outwardly from the outer periphery84 of one or both of thedelivery wire31 and theimplant wire33. A portion of one or more weld joints88 can extend radially inwardly from the outer periphery84 of one or both of thedelivery wire31 and theimplant wire33.
According to some embodiments, each weld joint88 can be circumferentially displaced from a circumferentially adjacent weld joint88. The weld joints88 can be distributed about a central axis with or without radial symmetry. A void or open space of the gap90 may remain between circumferentially adjacent weld joints68. A greater portion of the gap90 near the outer periphery84 may remain a void than the portion of the gap90 that is occupied by the weld joints68, each having a width92.
According to some embodiments, a radially centermost region of thedistal end41 can remain spaced apart from a radially centermost region of theproximal end43 by an axial gap. According to some embodiments, one or more weld joints88 may also be provided at radially inward locations (not shown), such as along a central axis of thedelivery wire31 and/or theimplant wire33.FIGS. 9A-B show four weld joints88. As will be appreciated, more or fewer than four weld joints may be provided, without departing from the scope of the disclosure. For example, thedetachment zone80 may provide 1, 2, 3, 4, 5, 6, 7, 8, 9, or more weld joints88.
According to some embodiments, as shown inFIG. 9B, in a cross-section of the gap90, a total area occupied by the weld joints88 can be less than a cross-sectional area of thedelivery wire31 and/or theimplant wire33. According to some embodiments, the weld joints88 can occupy no more than 5% of a zone (i) axially between theproximal end43 and thedistal end41 and (ii) radially within the radially outermost periphery84 of thedistal end41 and/or the radially outermost periphery of theproximal end43. According to some embodiments, at least 95% of this same zone can remain a void or open space.
Referring now toFIGS. 10 and 11A-11B, with continued reference toFIGS. 1-5, illustrated are various views of anexemplary detachment zone100, according to one or more embodiments of the subject technology. More particularly,FIG. 10 depicts a side view of thedelivery wire31 and theimplant wire33,FIG. 11A depicts a side view of thedetachment zone100 in a joined configuration, andFIG. 11B depicts a cross-sectional view of thedetachment zone100 in a joined configuration. Thedetachment zone100 may be similar in some respects to thedetachment zone30 ofFIGS. 4-5 and therefore may be best understood with reference thereto, where like numerals indicate like elements or components not described again in detail. Similar to thedetachment zone30 ofFIGS. 4-5, for example, thedetachment zone100 may join thedistal end41 of thedelivery wire31 to theproximal end43 of theimplant wire33.
According to some embodiments, as shown inFIG. 10, thedistal end41 of thedelivery wire31 can be brought into contact with theproximal end43 of theimplant wire33 at ajuncture110. According to some embodiments, as shown inFIG. 11A, one or more weld joints108 can be formed between thedistal end41 of thedelivery wire31 and theproximal end43 of theimplant wire33. According to some embodiments, the weld joints108 are portions (e.g., extensions or manipulated sections) of the respective structures that extend axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33, as described herein with respect to weld joints68. For example, the weld joints108 can be portions of either or both of thedelivery wire31 and theimplant wire33 that have been manipulated to extend across thejuncture110. Accordingly, thedelivery wire31 and theimplant wire33 can be connected without the addition of filler material. According to some embodiments, the weld joints108 are filler material, other than the material of thedelivery wire31 and theimplant wire33, that extend axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33, as described herein with respect to weld joints88.
According to some embodiments, as shown inFIG. 11B, some or all of the weld joints108 are located at a radiallyouter periphery104 of one or both of thedelivery wire31 and theimplant wire33. Substantially all of each weld joint108 can extend radially outwardly from theouter periphery104 of one or both of thedelivery wire31 and theimplant wire33. Accordingly, the weld joint108 can be provided substantially only at an exterior surface of theouter periphery104 of one or both of thedelivery wire31 and theimplant wire33.
According to some embodiments, each weld joint108 can be circumferentially displaced from a circumferentially adjacent weld joint108. The weld joints108 can be distributed about a central axis with or without radial symmetry.FIGS. 11A-B show four weld joints108. As will be appreciated, more or fewer than four weld joints may be provided, without departing from the scope of the disclosure. For example, thedetachment zone100 may provide 1, 2, 3, 4, 5, 6, 7, 8, 9, or more weld joints108. According to some embodiments, as shown inFIG. 11B, at thejuncture110, a total area occupied by the weld joints108, each having awidth112, can be less than a cross-sectional area of thedelivery wire31 and/or theimplant wire33.
Referring now toFIGS. 12 and 13A-13B, with continued reference toFIGS. 1-5, illustrated are various views of anexemplary detachment zone120, according to one or more embodiments of the subject technology. More particularly,FIG. 12 depicts a side view of thedelivery wire31 and theimplant wire33,FIG. 13A depicts a side view of thedetachment zone120 in a joined configuration, andFIG. 7B depicts a cross-sectional view of thedetachment zone120 in a joined configuration. Thedetachment zone120 may be similar in some respects to thedetachment zone30 ofFIGS. 4-5 and therefore may be best understood with reference thereto, where like numerals indicate like elements or components not described again in detail. Similar to thedetachment zone30 ofFIGS. 4-5, for example, thedetachment zone120 may join thedistal end41 of thedelivery wire31 to theproximal end43 of theimplant wire33.
According to some embodiments, as shown inFIG. 12, thedistal end41 of thedelivery wire31 can be brought to theproximal end43 of theimplant wire33, to provide agap130 there between. Thegap130 can be any size that facilitates application of weld joint128. For example, thegap130 can be less than the diameter of thedelivery wire31 and/or theimplant wire33. By further example, thegap130 can be zero, where at least a portion of thedelivery wire31 contacts theimplant wire33.
According to some embodiments, as shown inFIG. 13A, a single, continuous, annular weld joint128 can be formed between thedistal end41 of thedelivery wire31 and theproximal end43 of theimplant wire33. According to some embodiments, the weld joint128 is formed by portions of the respective structures that extend axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33, as described herein with respect to weld joints68. According to some embodiments, the weld joint128 is filler material, other than the material of thedelivery wire31 and theimplant wire33, that extend axially from thedistal end41 and/or another portion of thedelivery wire31 to theproximal end43 and/or another portion of theimplant wire33, as described herein with respect to weld joints88.
According to some embodiments, as shown inFIG. 13B, the weld joint128 can extend continuously and circumferentially at or about a radiallyouter periphery124 of one or both of thedelivery wire31 and theimplant wire33. A portion of the weld joint128 can extend radially outwardly from theouter periphery124 of one or both of thedelivery wire31 and theimplant wire33. A portion of the weld joint128 can extend radially inwardly from theouter periphery124 of one or both of thedelivery wire31 and theimplant wire33.
According to some embodiments, a radially centermost region of thedistal end41 can remain spaced apart from a radially centermost region of theproximal end43 by an axial gap. According to some embodiments, as shown inFIG. 13B, in a cross-section of thegap130, a total area occupied by the weld joint128 can be less than a cross-sectional area of thedelivery wire31 and/or theimplant wire33.
Relative to a single monolithic wire of uniform diameter, the arrangement of weld joints68,88,108, or128 (1) decreases the amount of material that must be eroded to achieve detachment and (2) increases the exposed surface area on which erosion can occur. Furthermore, each weld joint68,88,108, or128 can be of a rigid material that maintains column strength, such that forces applied by a user to thedelivery wire31 are fully or substantially transmitted to theimplant wire33. Providing weld joints68,88,108, or128 at anouter periphery64,84,104, or124 helps resist bending at the joining ofdelivery wire31 andimplant wire33.
According to some embodiments, adetachment zone30,60,80,100, or120 can be configured such that the corrodible portion thereof defines a unique structure configured to enhance electrolytic corrosion while preserving the structural characteristics thereof. A reduction in corrosion resistance will reduce a time required to deploy an intravascular and/or intrasaccular implant, thus reducing the overall procedure time. According to some embodiments, corrosion resistance ofdetachment zone30,60,80,100, or120 is decreased by exposure to laser or other energy in the formation thereof, causing thedetachment zone30,60,80,100, or120 to be structurally modified by heat. As a result, thedetachment zone30,60,80,100, or120 will have a different microstructure than the material outside of the zone (e.g., thedelivery wire31 and/or the implant wire33). The result will decrease the time to electrolytically plate off the material, resulting in faster detachment times. Energy provided to form adetachments zone30,60,80,100, or120 (e.g., a laser beam, an electron beam, a gas flame, an electric arc, friction, and/or ultrasound) can create surface defects for a reduction in corrosion resistance. The energy can also alter the microstructure at the detachment zone, leading to a non-uniform corrosion rate. Accordingly, the detachment zone can have a faster corrosion and detach time than that of thedelivery wire31 and/orimplant wire33.
According to some embodiments, thedelivery wire31 and/or theimplant wire33 have a microstructure with a crystallinity that is greater than a crystallinity of a microstructure of thedetachment zone30,60,80,100, or120. According to some embodiments, thedetachment zone30,60,80,100, or120 comprises a microstructure that is more amorphous than each of (i) a microstructure of thedelivery wire31 and (ii) a microstructure of theimplant wire33. According to some embodiments, a method of forming a delivery system includes providing adelivery wire31 and animplant wire33 and forming adetachment zone30,60,80,100, or120 between thedelivery wire31 and theimplant wire33. In the forming thereof, thedetachment zone30,60,80,100, or120 (e.g., weld joints68,88,108, or128) achieves a microstructure that is more amorphous than each of (i) a microstructure of thedelivery wire31 and (ii) a microstructure of theimplant wire33.
According to some embodiments, weld joints68,88,108, or128 can form one or more of a variety of shapes and sizes, as shown inFIGS. 7A-7B, 9A-9B, 11A-11B, and 13A-13B. For example, the cross-sectional profile of adetachment zone30 can define at least one concavity, valley, recess, and/or indentation formed therein. In accordance with some embodiments, the cross-sectional profile of the detachment zone can define areas of positive curvature, such as one or more peaks, protrusions, and/or convexities, with areas of negative curvature, such as one or more valleys, recesses, concavities, and/or indentations. The one or more peaks, protrusions, and/or convexities and the one or more valleys, recesses, concavities, or indentations can be formed from surface structures such as grooves, channels, pits, threads, elongate troughs, circumferential or annular grooves, slots, apertures, coils, crimped ribbon, slotted ribbon, perforated ribbon, and/or other such structures that are precisely or randomly arranged. The shape of the cross-sectional profile of the connector body can be defined by one or more linear edges, parallel linear edges, intersecting linear edges, continuous curves, and/or combinations thereof. By providing a surface structure or texture, some embodiments can thereby provide an increased surface area of the detachment zone in order to enhance the connection byweld joints68,88,108, or128, reduce the overall volume of the detachment zone, and thereby improve the rate of corrosion. Further, various embodiments can be provided that are configured to provide excellent structural characteristics in order to ensure that the detachment zone is sufficiently robust and durable. For example, in some embodiments, the component can have a component body comprising at least one structure, such as a trough, valley, recess, concavity, or indentation defining a recess surface area. In accordance with some embodiments, the component can be configured such that the valley, recess, concavity, or indentation can be used in the component without reducing structural characteristics of the component.
Further, the structure of the detachment zone can add recess surface area to the overall surface area of the detachment zone, thereby enhancing electrolytic corrosion of the detachment zone. Thus, the ratio of surface area to volume of the detachment zone can increase with an increase in overall surface area and a decrease in volume of the component. As discussed herein, the increase in the overall surface area of the detachment zone can be achieved by the incremental addition of surface area of the structure (e.g., the valley, recess, concavity, or indentation) versus the surface area of a surface without such a structure (e.g., a planar surface). The decrease in volume can be achieved by the addition of the void created by the valley, recess, concavity, or indentation.
Additionally, the detachment zone can be fabricated to provide features that will lead to an increased current density in one or more areas of the detachment zone. Such features can include, for example, ridges, edges, small radius corners, valleys, troughs, concavities, recesses, indentations, and/or other structures. In some embodiments, the presence of some of these structures on the detachment zone can reduce the local cross sectional area and/or otherwise contribute to the galvanic reaction. Features that increase current density can accelerate the galvanic reaction.
Other features and discussion of electrolytically corrodible connections is provided in other applications of the present assignee, including the discussion and disclosure of U. S. Patent Application Publication No. 2012/0010648 and U.S. Pat. Nos. 7,323,000, and 8,048,104, the entirety of each of which is incorporated herein by reference.
Electrolytically non-corrodible sections of the delivery wire can contain one or more of the following materials: noble metals or noble metal alloys, corrosion-resistant ceramic materials, corrosion-resistant plastics, and/or platinum metal alloys. The use of the above mentioned materials for the formation of electrolytically non-corrodible sections and of the electrolytically corrodible flanges ensures specific electrolytic corrosion of the flanges at the predetermined points.
In accordance with some embodiments, the electrolytically corrodible detachment zone can also be pre-corroded by etching or other methods. Thus, the structure(s) of a given cross-sectional profile can be modified to reduce the presence of corners, increase the recess depth, and/or otherwise enhance the corrosion rate. Further, various excellent structural designs can be provided to achieve desired corrosion performance through the teachings disclosed herein without pre-corrosion of the corrodible points.
Some embodiments can include a corrodible detachment zone that has a partial coating of a material to provide a greater or lesser electrochemical resistance. Thus, in embodiments that have one or more corrodible points, the electrochemical resistance of the points can be varied to achieve staged or preferential electrochemical resistance. Coatings of Zn, Sn, or alloys of such metals on fittings of stainless steel have been found to be particularly satisfactory.
Embodiments disclosed herein can be used in veterinary or human medicine and more particularly, for the endovascular treatment of intracranial aneurysms and acquired or innate arteriovenous blood vessel deformities and/or fistulas and/or for the embolization of tumors.
The apparatus and methods discussed herein are not limited to the deployment and use of an occluding device within any particular vessels, but can include any number of different types of vessels. For example, in some aspects, vessels can include arteries or veins. In some aspects, the vessels can be suprathoracic vessels (e.g., vessels in the neck or above), intrathoracic vessels (e.g., vessels in the thorax), subthoracic vessels (e.g., vessels in the abdominal area or below), lateral thoracic vessels (e.g., vessels to the sides of the thorax such as vessels in the shoulder area and beyond), or other types of vessels and/or branches thereof.
In some aspects, the stent delivery systems disclosed herein can be deployed within superthoracic vessels. The suprathoracic vessels can comprise at least one of intracranial vessels, cerebral arteries, and/or any branches thereof. In some aspects, the stent delivery systems disclosed herein can be deployed within intrathoracic vessels. The intrathoracic vessels can comprise the aorta or branches thereof. In some aspects, the stent delivery systems disclosed herein can be deployed within subthoracic vessels. In some aspects, the stent delivery systems disclosed herein can be deployed within lateral thoracic vessels.
The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.
There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.
A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as “an aspect” may refer to one or more aspects and vice versa. A phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such “an embodiment” may refer to one or more embodiments and vice versa. A phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as “a configuration” may refer to one or more configurations and vice versa.
It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplary approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
As used herein, the phrase “at least one of” preceding a series of items, with the term “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (i.e., each item). The phrase “at least one of” does not require selection of at least one of each item listed; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items. By way of example, the phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
Terms such as “top,” “bottom,” “front,” “rear” and the like as used in this disclosure should be understood as referring to an arbitrary frame of reference, rather than to the ordinary gravitational frame of reference. Thus, a top surface, a bottom surface, a front surface, and a rear surface may extend upwardly, downwardly, diagonally, or horizontally in a gravitational frame of reference.
Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments.
A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” Pronouns in the masculine (e.g., his) include the feminine and neuter gender (e.g., her and its) and vice versa. The term “some” refers to one or more. Underlined and/or italicized headings and subheadings are used for convenience only, do not limit the subject technology, and are not referred to in connection with the interpretation of the description of the subject technology. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.
While certain aspects and embodiments of the subject technology have been described, these have been presented by way of example only, and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the subject technology.

Claims (17)

What is claimed is:
1. A delivery system, comprising:
a core member having a distal end;
an implant, having a proximal end;
an axial gap between the distal end and the proximal end;
one or more weld joints disposed in the gap, the one or more weld joints being further disposed at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end; and
a void in a radially centermost region of the gap.
2. The delivery system ofclaim 1, wherein the one or more weld joints are of a material more susceptible to electrolytic corrosion than each of the distal end of the core member and the proximal end of the implant.
3. The delivery system ofclaim 1, wherein the one or more weld joints comprises a plurality of weld joints disposed axially between the distal end and the proximal end, the plurality of weld joints being distributed about the radially outermost periphery of the distal end and the radially outermost periphery of the proximal end.
4. The delivery system ofclaim 3, wherein the plurality of weld joints are evenly distributed about the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end.
5. The delivery system ofclaim 1, wherein the distal end connects to the proximal end only via the one or more weld joints.
6. The delivery system ofclaim 1, wherein the one or more weld joints occupy no more than 5% of a zone (i) axially between the proximal end and the distal end and (ii) radially within the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end.
7. The delivery system ofclaim 1, wherein the void comprises least 95% of a zone (i) axially between the proximal end and the distal end and (ii) radially within the radially outermost periphery of the distal end and/or the radially outermost periphery of the proximal end.
8. A method of delivering a detachable implant, comprising
advancing, to a target location within a patient, an implant having a proximal end and being connected to a distal end of a core member by one or more weld joints disposed axially between the distal end and the proximal end, the one or more weld joints being further disposed at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end, the one or more weld joints defining a void between the distal end and the proximal end; and
separating the implant from the core member by corroding the one or more weld joints.
9. The method ofclaim 8, wherein the separating the implant from the core member comprises electrolytically corroding the one or more weld joints.
10. The method ofclaim 8, wherein the separating the implant from the core member comprises applying an electrical current through the core member to the one or more weld joints while the one or more weld joints are in an electrolyte solution.
11. The method ofclaim 8, wherein, during the separating, a radially centermost region of the distal end is spaced apart from a radially centermost region of the proximal end by an axial gap, and wherein the void is disposed in the gap.
12. The method ofclaim 8, wherein the advancing comprises:
advancing a distal end of a catheter, containing the implant, near the target location; and
advancing the implant out of the distal end of the catheter and into the target location.
13. The method ofclaim 8, further comprising withdrawing the core member.
14. A method of making a detachable implant, comprising
aligning, along a central axis, a distal end of a core member to be axially adjacent to a proximal end of an implant;
maintaining an axial gap between the proximal end and the distal end; and
forming, at least partially from the proximal end and the distal end, one or more weld joints at a radially outermost periphery of the distal end and a radially outermost periphery of the proximal end such that a void is disposed in a radially centermost region of the gap.
15. The method ofclaim 14, wherein the forming comprises applying a filler material that forms a portion of the one or more weld joints.
16. The method ofclaim 14, wherein the one or more weld joints are at least partially of a material more susceptible to electrolytic corrosion than each of the distal end of the core member and the proximal end of the implant.
17. The method ofclaim 14, wherein the forming comprises connecting the distal end to the proximal end only via the one or more weld joints.
US14/708,6612015-05-112015-05-11Electrolytic detachment for implant delivery systemsActive2035-07-22US9717503B2 (en)

Priority Applications (6)

Application NumberPriority DateFiling DateTitle
US14/708,661US9717503B2 (en)2015-05-112015-05-11Electrolytic detachment for implant delivery systems
CA2927874ACA2927874C (en)2015-05-112016-04-21Electrolytic detachment for implant delivery systems
EP16166685.4AEP3092956B1 (en)2015-05-112016-04-22Electrolytic detachment for implant delivery systems
JP2016090676AJP6203327B2 (en)2015-05-112016-04-28 Electrolytic separation for implant delivery systems
KR1020160055086AKR101788972B1 (en)2015-05-112016-05-04Electrolytic detachment for implant delivery systems
CN201610304068.8ACN106137294B (en)2015-05-112016-05-10The electrolytically detaching of implantation material delivery system

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US14/708,661US9717503B2 (en)2015-05-112015-05-11Electrolytic detachment for implant delivery systems

Publications (2)

Publication NumberPublication Date
US20160331381A1 US20160331381A1 (en)2016-11-17
US9717503B2true US9717503B2 (en)2017-08-01

Family

ID=56087076

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US14/708,661Active2035-07-22US9717503B2 (en)2015-05-112015-05-11Electrolytic detachment for implant delivery systems

Country Status (6)

CountryLink
US (1)US9717503B2 (en)
EP (1)EP3092956B1 (en)
JP (1)JP6203327B2 (en)
KR (1)KR101788972B1 (en)
CN (1)CN106137294B (en)
CA (1)CA2927874C (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US9918718B2 (en)2014-08-082018-03-20DePuy Synthes Products, Inc.Embolic coil delivery system with retractable mechanical release mechanism
CN113952095B (en)*2015-09-182025-06-06微仙美国有限公司 Implant retention, detachment and delivery systems
US20170214268A1 (en)*2016-01-222017-07-27Boston Scientific Neuromodulation CorporationPhysically-Configurable External Charger for an Implantable Medical Device with Separable Coil and Electronics Housings
US10576099B2 (en)2016-10-212020-03-03Covidien LpInjectable scaffold for treatment of intracranial aneurysms and related technology
US10376396B2 (en)*2017-01-192019-08-13Covidien LpCoupling units for medical device delivery systems
CN108339195B (en)*2017-01-222020-06-26北京市神经外科研究所Device and method for forming electric thrombus
GB201713329D0 (en)*2017-08-182017-10-04Clearstream Tech LtdAn implant system comprising a delivery wire assembly and an implant
CN107714243B (en)*2017-09-292021-05-07依奈德医疗技术(上海)有限公司Self-expansion type nasal stent
US10806462B2 (en)2017-12-212020-10-20DePuy Synthes Products, Inc.Implantable medical device detachment system with split tube and cylindrical coupling
US10806461B2 (en)*2018-04-272020-10-20DePuy Synthes Products, Inc.Implantable medical device detachment system with split tube
US11147562B2 (en)2018-12-122021-10-19DePuy Synthes Products, Inc.Systems and methods for embolic implant detachment
US11253265B2 (en)2019-06-182022-02-22DePuy Synthes Products, Inc.Pull wire detachment for intravascular devices
US11207494B2 (en)2019-07-032021-12-28DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11426174B2 (en)2019-10-032022-08-30DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant mechanical release
US11439403B2 (en)2019-09-172022-09-13DePuy Synthes Products, Inc.Embolic coil proximal connecting element and stretch resistant fiber
US12376859B2 (en)2019-09-172025-08-05DePuy Synthes Products, Inc.Embolic coil proximal connecting element and stretch resistant fiber
WO2021092618A1 (en)*2019-11-042021-05-14Covidien LpDevices, systems, and methods for treatment of intracranial aneurysms
US11376013B2 (en)2019-11-182022-07-05DePuy Synthes Products, Inc.Implant delivery system with braid cup formation
CN110755125B (en)*2019-11-212025-02-21上海加奇生物科技苏州有限公司 A delivery and release device for implants
US11457922B2 (en)2020-01-222022-10-04DePuy Synthes Products, Inc.Medical device delivery member with flexible stretch resistant distal portion
US11432822B2 (en)2020-02-142022-09-06DePuy Synthes Products, Inc.Intravascular implant deployment system
US11951026B2 (en)2020-06-302024-04-09DePuy Synthes Products, Inc.Implantable medical device detachment system with flexible braid section
US11998213B2 (en)2021-07-142024-06-04DePuy Synthes Products, Inc.Implant delivery with modified detachment feature and pull wire engagement
US11937824B2 (en)2021-12-302024-03-26DePuy Synthes Products, Inc.Implant detachment systems with a modified pull wire
US11844490B2 (en)2021-12-302023-12-19DePuy Synthes Products, Inc.Suture linkage for inhibiting premature embolic implant deployment
US12011171B2 (en)2022-01-062024-06-18DePuy Synthes Products, Inc.Systems and methods for inhibiting premature embolic implant deployment
US11937825B2 (en)2022-03-022024-03-26DePuy Synthes Products, Inc.Hook wire for preventing premature embolic implant detachment
US12137915B2 (en)2022-03-032024-11-12DePuy Synthes Products, Inc.Elongating wires for inhibiting premature implant detachment
US11937826B2 (en)2022-03-142024-03-26DePuy Synthes Products, Inc.Proximal link wire for preventing premature implant detachment
CN114939013A (en)*2022-05-312022-08-26上海微创医疗器械(集团)有限公司Vascular reconstruction device, pushing device and medical system
US12402886B2 (en)2022-06-232025-09-02DePuy Synthes Products, Inc.Detachment indicator for implant deployment
US12396730B2 (en)2022-09-282025-08-26DePuy Synthes Products, Inc.Braided implant with detachment mechanism

Citations (136)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1991013592A1 (en)1990-03-131991-09-19The Regents Of The University Of CaliforniaEndovascular electrolytically detachable guidewire tip
US5108407A (en)1990-06-081992-04-28Rush-Presbyterian St. Luke's Medical CenterMethod and apparatus for placement of an embolic coil
US5250071A (en)1992-09-221993-10-05Target Therapeutics, Inc.Detachable embolic coil assembly using interlocking clasps and method of use
US5354295A (en)1990-03-131994-10-11Target Therapeutics, Inc.In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5370653A (en)1993-07-221994-12-06Micro Therapeutics, Inc.Thrombectomy method and apparatus
WO1995012367A1 (en)1993-11-031995-05-11Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US5509411A (en)1993-01-291996-04-23Cardima, Inc.Intravascular sensing device
US5522836A (en)1994-06-271996-06-04Target Therapeutics, Inc.Electrolytically severable coil assembly with movable detachment point
DE4445715A1 (en)1994-12-221996-06-27Henkes Hans Dr MedArrangement for inserting implant into blood vessel or body chamber
EP0719522A1 (en)1994-12-301996-07-03Target Therapeutics, Inc.Solderless electrolytically severable joint for detachable devices placed withinthe mammalian body
EP0739606A1 (en)1995-04-281996-10-30Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US5658308A (en)1995-12-041997-08-19Target Therapeutics, Inc.Bioactive occlusion coil
US5690667A (en)1996-09-261997-11-25Target TherapeuticsVasoocclusion coil having a polymer tip
US5733329A (en)1996-12-301998-03-31Target Therapeutics, Inc.Vaso-occlusive coil with conical end
US5743905A (en)1995-07-071998-04-28Target Therapeutics, Inc.Partially insulated occlusion device
US5749894A (en)1996-01-181998-05-12Target Therapeutics, Inc.Aneurysm closure method
US5766629A (en)1995-08-251998-06-16Sangstat Medical CorporationOral cyclosporin formulations
US5800455A (en)1993-04-191998-09-01Target Therapeutics, Inc.Detachable embolic coil assembly
US5851206A (en)1990-03-131998-12-22The Regents Of The University Of CaliforniaMethod and apparatus for endovascular thermal thrombosis and thermal cancer treatment
US5853418A (en)1995-06-301998-12-29Target Therapeutics, Inc.Stretch resistant vaso-occlusive coils (II)
US5855578A (en)1990-03-131999-01-05The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
WO1999009894A1 (en)1997-08-291999-03-04Boston Scientific LimitedFast detaching electrically isolated implant
US5916235A (en)1997-08-131999-06-29The Regents Of The University Of CaliforniaApparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US5925059A (en)1993-04-191999-07-20Target Therapeutics, Inc.Detachable embolic coil assembly
US5935145A (en)1998-02-131999-08-10Target Therapeutics, Inc.Vaso-occlusive device with attached polymeric materials
US5941888A (en)1998-02-181999-08-24Target Therapeutics, Inc.Vaso-occlusive member assembly with multiple detaching points
US5964797A (en)1996-08-301999-10-12Target Therapeutics, Inc.Electrolytically deployable braided vaso-occlusion device
US6013084A (en)1995-06-302000-01-11Target Therapeutics, Inc.Stretch resistant vaso-occlusive coils (II)
US6059779A (en)1995-04-282000-05-09Target Therapeutics, Inc.Delivery catheter for electrolytically detachable implant
US6063104A (en)1998-06-242000-05-16Target Therapeutics, Inc.Detachable, varying flexibility, aneurysm neck bridge
US6063070A (en)1997-08-052000-05-16Target Therapeutics, Inc.Detachable aneurysm neck bridge (II)
US6077260A (en)1998-02-192000-06-20Target Therapeutics, Inc.Assembly containing an electrolytically severable joint for endovascular embolic devices
US6136015A (en)1998-08-252000-10-24Micrus CorporationVasoocclusive coil
US6146373A (en)1997-10-172000-11-14Micro Therapeutics, Inc.Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6156061A (en)1997-08-292000-12-05Target Therapeutics, Inc.Fast-detaching electrically insulated implant
US6168618B1 (en)1998-01-272001-01-02Endotex Interventional Systems, Inc.Electrolytic stent delivery system and methods of use
US6168615B1 (en)1998-05-042001-01-02Micrus CorporationMethod and apparatus for occlusion and reinforcement of aneurysms
US6168592B1 (en)1996-07-262001-01-02Target Therapeutics, Inc.Aneurysm closure device assembly
WO2001032085A1 (en)1999-10-302001-05-10Dendron GmbhDevice for implanting occlusion coils
US6238403B1 (en)1999-10-042001-05-29Microvention, Inc.Filamentous embolic device with expansible elements
US6241691B1 (en)1997-12-052001-06-05Micrus CorporationCoated superelastic stent
US6280457B1 (en)1999-06-042001-08-28Scimed Life Systems, Inc.Polymer covered vaso-occlusive devices and methods of producing such devices
US6296622B1 (en)1998-12-212001-10-02Micrus CorporationEndoluminal device delivery system using axially recovering shape memory material
US6416373B1 (en)2000-10-122002-07-09Bombardier Motor Corporation Of AmericaOil system vent with remote oil reservoir
US6425893B1 (en)1990-03-132002-07-30The Regents Of The University Of CaliforniaMethod and apparatus for fast electrolytic detachment of an implant
DE10118017A1 (en)2001-04-102002-10-17Dendron GmbhUnit for implanting occlusion coils into body cavities or blood vessels via a catheter, comprises a safety device which contains a material with shape memory
US6468301B1 (en)2000-03-272002-10-22Aga Medical CorporationRepositionable and recapturable vascular stent/graft
US6478773B1 (en)1998-12-212002-11-12Micrus CorporationApparatus for deployment of micro-coil using a catheter
US6485524B2 (en)1997-01-312002-11-26Ernst-Peter StreckerStent for treating pathological body vessels
US6486266B2 (en)1998-05-112002-11-26Nisshinbo Industries, Inc.Thermosetting resin composition
US6511468B1 (en)1997-10-172003-01-28Micro Therapeutics, Inc.Device and method for controlling injection of liquid embolic composition
US6602261B2 (en)1999-10-042003-08-05Microvention, Inc.Filamentous embolic device with expansile elements
US20030176857A1 (en)2000-07-262003-09-18Lee Kyu HoAssembly for embolic treatments
US20030212426A1 (en)*2002-05-082003-11-13Olson, Stanley W.Tactical detachable anatomic containment device and therapeutic treatment system
US20040002731A1 (en)2002-06-272004-01-01Nestor AganonAnchor assemblies in stretch-resistant vaso-occlusive coils
US6723112B2 (en)1998-11-102004-04-20Scimed Life Systems, Inc.Bioactive three loop coil
EP1420701A1 (en)2001-08-272004-05-26Dendron GmbHDevice for the implantation of occlusion means
US6743251B1 (en)2000-11-152004-06-01Scimed Life Systems, Inc.Implantable devices with polymeric detachment junction
US20040225279A1 (en)2001-06-012004-11-11Jean RaymondDetachable tip microcatheter for use of liquid embolic agents
US6835185B2 (en)1998-12-212004-12-28Micrus CorporationIntravascular device deployment mechanism incorporating mechanical detachment
US20050079196A1 (en)2001-11-122005-04-14Hans HenkesMedical implant
US6905503B2 (en)2001-02-092005-06-14Concentric Medical, Inc.Methods and devices for delivering occlusion elements
US6936055B1 (en)1997-08-052005-08-30Scime Life Systems, Inc.Detachable aneurysm neck bridge (III)
US6953473B2 (en)2001-12-202005-10-11Boston Scientific Scimed, Inc.Detachable device with electrically responsive element
US20060036281A1 (en)2004-05-212006-02-16Micro Therapeutics, Inc.Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
US7014645B2 (en)1999-10-042006-03-21Microvention Inc.Method of manufacturing expansile filamentous embolization devices
US20060100602A1 (en)2001-01-262006-05-11William Cook Europe ApsEndovascular medical device with plurality of wires
US20060135986A1 (en)2004-12-222006-06-22Scimed Life Systems, Inc.Vaso-occlusive device having pivotable coupling
US7083567B2 (en)1993-09-152006-08-01Michel E. MawadRetrievable, shielded radiotherapy implant
US7128736B1 (en)1998-09-042006-10-31Boston Scientific Scimed, Inc.Detachable aneurysm neck closure patch
US20060271097A1 (en)2005-05-312006-11-30Kamal RamzipoorElectrolytically detachable implantable devices
US7169172B2 (en)2002-11-012007-01-30Counter Clockwise, Inc.Method and apparatus for caged stent delivery
US20070073334A1 (en)2005-09-292007-03-29Kamal RamzipoorCombined electrolytic and mechanical separation background
EP1843710A1 (en)2005-02-042007-10-17Boston Scientific LimitedVaso-occlusive devices including non-biodegradable biomaterials
US7300458B2 (en)2002-07-192007-11-27Micro Therapeutics, Inc.Medical implant having a curlable matrix structure
EP1884208A1 (en)2005-05-242008-02-06Kaneka CorporationMedical wire
US7331974B2 (en)2000-09-262008-02-19Microvention, Inc.Microcoil vaso-occlusive device with multi-axis secondary configuration
US20080051803A1 (en)2000-10-302008-02-28Dendron GmbhDevice for the implantation of occlusion spirals
US20080103585A1 (en)*2004-09-222008-05-01Dendron GmbhMicro-Spiral Implantation Device
EP1951129A2 (en)2005-10-192008-08-06Pulsar Vascular, IncorporatedMethods and systems for endovascularly clipping and repairing lumen and tissue defects
US20080221666A1 (en)2006-12-152008-09-11Cardiomind, Inc.Stent systems
US20080228216A1 (en)2007-03-132008-09-18Micro Therapeutics Inc.Implant, a mandrel, and a method of forming an implant
US20080228215A1 (en)2007-03-132008-09-18Micro Therapeutics, Inc.Implant including a coil and a stretch-resistant member
US20080319532A1 (en)2004-09-222008-12-25Ev3, Inc.Medical Implant
US20090143786A1 (en)2007-12-032009-06-04Boston Scientific Scimed, Inc.Implantable device with electrolytically detachable junction having multiple fine wires and method of introduction
US20090227976A1 (en)*2008-03-052009-09-10Calabria Marie FMultiple biocompatible polymeric strand aneurysm embolization system and method
US20090254111A1 (en)2005-04-282009-10-08Hermann MonstadtDevice for implanting occlusion spirals comprising an interior securing element
USRE41029E1 (en)1990-03-132009-12-01The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US7651513B2 (en)2003-04-032010-01-26Boston Scientific Scimed, Inc.Flexible embolic device delivery system
EP2146651A2 (en)2007-03-212010-01-27Micrus Endovascular CorporationApparatus and method for deployment of a therapeutic device using a catheter
US20100023105A1 (en)2008-07-222010-01-28Micro Therapeutics, Inc.Vascular remodeling device
US20100030200A1 (en)2006-04-172010-02-04Micro Therapeutics, Inc.System and method for mechanically positioning intravascular implants
US20100049165A1 (en)2008-08-192010-02-25Micro Therapeutics, IncDetachable tip microcatheter
US20100063572A1 (en)2008-09-092010-03-11Boston Scientific Scimed, Inc.Composite detachment mechanisms
US20100076479A1 (en)2004-01-212010-03-25Hermann MonstadtDevice for implanting electrically isolated occlusion helixes
US20100256666A1 (en)2009-04-062010-10-07Boston Scientific Scimed, Inc.Delivery wire for occlusive device delivery system
US20100268204A1 (en)2009-04-152010-10-21Microvention, Inc.Implant Delivery System
US20100331948A1 (en)2009-06-262010-12-30Cardiomind, Inc.Implant delivery apparatus and methods with electrolytic release
US20110106128A1 (en)2009-11-022011-05-05Boston Scientific Scimed, Inc.Delivery wire assembly for occlusive device delivery system
US20110118768A1 (en)2003-01-072011-05-19Tri TranOcclusive cinching devices and methods of use
US20110184453A1 (en)2010-01-282011-07-28Micro Therapeutics, Inc.Vascular remodeling device
US8002789B2 (en)2005-05-312011-08-23Stryker CorporationStretch-resistant vaso-occlusive devices with flexible detachment junctions
US8016869B2 (en)2003-03-262011-09-13Biosensors International Group, Ltd.Guidewire-less stent delivery methods
US8021416B2 (en)1999-12-102011-09-20Stryker CorporationMethods for delivering a prosthesis to a site in a body
US8157855B2 (en)2003-12-052012-04-17Boston Scientific Scimed, Inc.Detachable segment stent
US8202292B2 (en)2008-10-132012-06-19Stryker CorporationVaso-occlusive coil delivery system
US8221396B2 (en)2009-08-272012-07-17Silver Bullet Therapeutics, Inc.Bone implants for the treatment of infection
US8221483B2 (en)2007-05-182012-07-17Stryker CorporationMedical implant detachment systems and methods
US20120209310A1 (en)2011-02-102012-08-16Stryker Nv Operations LimitedVaso-occlusive device delivery system
US8273116B2 (en)2005-11-022012-09-25Biosensors International Group, Ltd.Indirect-release electrolytic implant delivery systems
WO2012166804A1 (en)2011-06-032012-12-06Reverse Medical CorporationEmbolic implant and method of use
US8398671B2 (en)2009-04-162013-03-19Stryker CorporationElectrical contact for occlusive device delivery system
EP2575697A1 (en)2010-05-282013-04-10Phenox GmbHDevice for inserting an implant
US20130184743A1 (en)2009-04-162013-07-18Stryker Nv Operations LimitedElectrical contact for occlusive device delivery system
WO2013119332A2 (en)2012-02-092013-08-15Stout Medical Group, L.P.Embolic device and methods of use
US20130211492A1 (en)2010-09-082013-08-15Manuel SchneiderImplant for influencing the blood flow in arteriovenous defects
US8562667B2 (en)2001-07-202013-10-22Microvention, Inc.Aneurysm treatment device and method of use
EP2668914A1 (en)2012-06-012013-12-04Acandis GmbH & Co. KGImplant system
US20140005651A1 (en)2011-03-022014-01-02Joe Michael EskridgeApparatus and method for positioning an implantable device
US8641746B2 (en)2005-05-312014-02-04J.W. Medical Systems Ltd.In situ stent formation
US20140039535A1 (en)2012-08-032014-02-06Tyco Healthcare Group LpDevice for implantation of medical devices
US8715312B2 (en)2001-07-202014-05-06Microvention, Inc.Aneurysm treatment device and method of use
US8777979B2 (en)2006-04-172014-07-15Covidien LpSystem and method for mechanically positioning intravascular implants
US20140277092A1 (en)2013-03-142014-09-18Stryker Nv Operations LimitedVaso-occlusive device delivery system
US20140277094A1 (en)2013-03-142014-09-18Stryker Nv Operations LimitedVaso-occlusive device delivery system
US8870909B2 (en)2001-07-202014-10-28Microvention, Inc.Aneurysm treatment device and method of use
US8915950B2 (en)2010-12-062014-12-23Covidien LpVascular remodeling device
US20150005804A1 (en)2011-01-172015-01-01Nicholas FrananoExpandable body device and method of use
US8932317B2 (en)1999-06-022015-01-13Microvention, Inc.Intracorporeal occlusive device and method
US20150057700A1 (en)2013-08-202015-02-26Stryker CorporationVaso-occlusive device delivery system
US20150066073A1 (en)2013-09-032015-03-05Jianlu MaDetachment mechanisms for implantable devices
US8998926B2 (en)2006-04-062015-04-07DePuy Synthes Products, LLCHeat detachable coil
US20150105817A1 (en)2008-05-022015-04-16Sequent Medical Inc.Filamentary devices for treatment of vascular defects
US20150133990A1 (en)2013-11-132015-05-14Covidien LpGalvanically assisted attachment of medical devices to thrombus
US9039749B2 (en)2010-10-012015-05-26Covidien LpMethods and apparatuses for flow restoration and implanting members in the human body
US9055948B2 (en)2004-11-092015-06-16Stryker CorporationVaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6022369A (en)*1998-02-132000-02-08Precision Vascular Systems, Inc.Wire device with detachable end
US6558390B2 (en)*2000-02-162003-05-06Axiamed, Inc.Methods and apparatus for performing therapeutic procedures in the spine
EP2633823B1 (en)2008-04-212016-06-01Covidien LPBraid-ball embolic devices and delivery systems
US8734500B2 (en)*2011-09-272014-05-27DePuy Synthes Products, LLCDistal detachment mechanisms for vascular devices
KR102211335B1 (en)*2013-12-202021-02-03마이크로벤션, 인코포레이티드Device delivery system

Patent Citations (245)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5947962A (en)1990-03-131999-09-07The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries veins aneurysms vascular malformations and arteriovenous fistulas
US5851206A (en)1990-03-131998-12-22The Regents Of The University Of CaliforniaMethod and apparatus for endovascular thermal thrombosis and thermal cancer treatment
US5122136A (en)1990-03-131992-06-16The Regents Of The University Of CaliforniaEndovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5928226A (en)1990-03-131999-07-27The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en)1990-03-131994-10-11Target Therapeutics, Inc.In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5925037A (en)1990-03-131999-07-20The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5919187A (en)1990-03-131999-07-06The Regents Of The University Of CaliforniaMethod and apparatus for endovascular thermal thrombosis and thermal cancer treatment
EP1329196A1 (en)1990-03-132003-07-23The Regents of the University of CaliforniaEndovascular electrolytically detachable guidewire tip
US5895385A (en)1990-03-131999-04-20The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6083220A (en)1990-03-132000-07-04The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
USRE42756E1 (en)1990-03-132011-09-27The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5944714A (en)1990-03-131999-08-31The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5540680A (en)1990-03-131996-07-30The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6066133A (en)1990-03-132000-05-23The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
WO1991013592A1 (en)1990-03-131991-09-19The Regents Of The University Of CaliforniaEndovascular electrolytically detachable guidewire tip
US5855578A (en)1990-03-131999-01-05The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
USRE41029E1 (en)1990-03-132009-12-01The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5947963A (en)1990-03-131999-09-07The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US20020151883A1 (en)1990-03-132002-10-17Guido GuglielmiMethod and apparatus for fast electrolyitic detachment of an implant
US6425893B1 (en)1990-03-132002-07-30The Regents Of The University Of CaliforniaMethod and apparatus for fast electrolytic detachment of an implant
US6010498A (en)1990-03-132000-01-04The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6620152B2 (en)1990-03-132003-09-16The Regents Of The University Of CaliforniaMethod and apparatus for fast electrolyitic detachment of an implant
US5976126A (en)1990-03-131999-11-02The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire and tip formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5108407A (en)1990-06-081992-04-28Rush-Presbyterian St. Luke's Medical CenterMethod and apparatus for placement of an embolic coil
EP0803230A2 (en)1992-02-241997-10-29The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire for thrombus formation
EP1005837A2 (en)1992-02-242000-06-07The Regents Of The University Of CaliforniaEndovascular electrolytically detachable wire for thrombus formation
US5250071A (en)1992-09-221993-10-05Target Therapeutics, Inc.Detachable embolic coil assembly using interlocking clasps and method of use
US5509411A (en)1993-01-291996-04-23Cardima, Inc.Intravascular sensing device
US5925059A (en)1993-04-191999-07-20Target Therapeutics, Inc.Detachable embolic coil assembly
US5800455A (en)1993-04-191998-09-01Target Therapeutics, Inc.Detachable embolic coil assembly
US5370653A (en)1993-07-221994-12-06Micro Therapeutics, Inc.Thrombectomy method and apparatus
US7083567B2 (en)1993-09-152006-08-01Michel E. MawadRetrievable, shielded radiotherapy implant
WO1995012367A1 (en)1993-11-031995-05-11Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US5423829A (en)1993-11-031995-06-13Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US5624449A (en)1993-11-031997-04-29Target TherapeuticsElectrolytically severable joint for endovascular embolic devices
EP0807410A2 (en)1993-11-031997-11-19Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US5522836A (en)1994-06-271996-06-04Target Therapeutics, Inc.Electrolytically severable coil assembly with movable detachment point
DE4445715A1 (en)1994-12-221996-06-27Henkes Hans Dr MedArrangement for inserting implant into blood vessel or body chamber
US5891128A (en)1994-12-301999-04-06Target Therapeutics, Inc.Solderless electrolytically severable joint for detachable devices placed within the mammalian body
US6123714A (en)1994-12-302000-09-26Target Therapeutics, Inc.System for detaching an occlusive device within a body using a solderless, electrolytically severable joint
US6589230B2 (en)1994-12-302003-07-08Target Therapeutics, Inc.System for detaching an occlusive device within a mammalian body using a solderless, electrolytically severable joint
EP0861634A2 (en)1994-12-301998-09-02Target Therapeutics, Inc.Solderless electrolytically severable joint for detachable devices placed within the mammalian body
EP0719522A1 (en)1994-12-301996-07-03Target Therapeutics, Inc.Solderless electrolytically severable joint for detachable devices placed withinthe mammalian body
EP0739606A1 (en)1995-04-281996-10-30Target Therapeutics, Inc.Electrolytically severable joint for endovascular embolic devices
US6059779A (en)1995-04-282000-05-09Target Therapeutics, Inc.Delivery catheter for electrolytically detachable implant
US6013084A (en)1995-06-302000-01-11Target Therapeutics, Inc.Stretch resistant vaso-occlusive coils (II)
US6193728B1 (en)1995-06-302001-02-27Target Therapeutics, Inc.Stretch resistant vaso-occlusive coils (II)
US5853418A (en)1995-06-301998-12-29Target Therapeutics, Inc.Stretch resistant vaso-occlusive coils (II)
US5743905A (en)1995-07-071998-04-28Target Therapeutics, Inc.Partially insulated occlusion device
US5766629A (en)1995-08-251998-06-16Sangstat Medical CorporationOral cyclosporin formulations
US5658308A (en)1995-12-041997-08-19Target Therapeutics, Inc.Bioactive occlusion coil
US5749894A (en)1996-01-181998-05-12Target Therapeutics, Inc.Aneurysm closure method
US6168592B1 (en)1996-07-262001-01-02Target Therapeutics, Inc.Aneurysm closure device assembly
US5964797A (en)1996-08-301999-10-12Target Therapeutics, Inc.Electrolytically deployable braided vaso-occlusion device
US5690667A (en)1996-09-261997-11-25Target TherapeuticsVasoocclusion coil having a polymer tip
US5733329A (en)1996-12-301998-03-31Target Therapeutics, Inc.Vaso-occlusive coil with conical end
US6485524B2 (en)1997-01-312002-11-26Ernst-Peter StreckerStent for treating pathological body vessels
US6063070A (en)1997-08-052000-05-16Target Therapeutics, Inc.Detachable aneurysm neck bridge (II)
US6936055B1 (en)1997-08-052005-08-30Scime Life Systems, Inc.Detachable aneurysm neck bridge (III)
US5916235A (en)1997-08-131999-06-29The Regents Of The University Of CaliforniaApparatus and method for the use of detachable coils in vascular aneurysms and body cavities
USRE43311E1 (en)1997-08-292012-04-10Stryker CorporationFast-detaching electrically insulated implant
WO1999009894A1 (en)1997-08-291999-03-04Boston Scientific LimitedFast detaching electrically isolated implant
US20030014073A1 (en)1997-08-292003-01-16Scimed Life Systems, Inc.Fast detaching electrically isolated implant
US6468266B1 (en)1997-08-292002-10-22Scimed Life Systems, Inc.Fast detaching electrically isolated implant
US6425914B1 (en)1997-08-292002-07-30Target Therapeutics, Inc.Fast-detaching electrically insulated implant
US6165178A (en)1997-08-292000-12-26Scimed Life Systems, Inc.Fast detaching electrically isolated implant
US5984929A (en)1997-08-291999-11-16Target Therapeutics, Inc.Fast detaching electronically isolated implant
US6156061A (en)1997-08-292000-12-05Target Therapeutics, Inc.Fast-detaching electrically insulated implant
US20030225365A1 (en)1997-10-172003-12-04Greff Richard J.Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6558367B1 (en)1997-10-172003-05-06Micro Therapeutics, Inc.Catheter system and method for injection of a liquid embolic composition and a solidification agent
US20030040733A1 (en)1997-10-172003-02-27Cragg Andrew H.Device and method for controlling injection of liquid embolic composition
US6511468B1 (en)1997-10-172003-01-28Micro Therapeutics, Inc.Device and method for controlling injection of liquid embolic composition
US6146373A (en)1997-10-172000-11-14Micro Therapeutics, Inc.Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6964657B2 (en)1997-10-172005-11-15Micro Therapeutics, Inc.Catheter system and method for injection of a liquid embolic composition and a solidification agent
US20080045922A1 (en)1997-10-172008-02-21Micro Therapeutics, Inc.Device and method for controlling injection of liquid embolic composition
US6241691B1 (en)1997-12-052001-06-05Micrus CorporationCoated superelastic stent
US6168618B1 (en)1998-01-272001-01-02Endotex Interventional Systems, Inc.Electrolytic stent delivery system and methods of use
US5935145A (en)1998-02-131999-08-10Target Therapeutics, Inc.Vaso-occlusive device with attached polymeric materials
US6533801B2 (en)1998-02-182003-03-18Target Therapeutics, Inc.Vaso-occlusive member assembly with multiple detaching points
US5941888A (en)1998-02-181999-08-24Target Therapeutics, Inc.Vaso-occlusive member assembly with multiple detaching points
US6623493B2 (en)1998-02-182003-09-23Target Therapeutics, Inc.Vaso-occlusive member assembly with multiple detaching points
US6371972B1 (en)1998-02-182002-04-16Target Therapeutics, Inc.Vaso-occlusive member assembly with multiple detaching points
US6589236B2 (en)1998-02-192003-07-08E. Thomas WheelockAssembly containing an electrolytically severable joint for endovascular embolic devices
US6077260A (en)1998-02-192000-06-20Target Therapeutics, Inc.Assembly containing an electrolytically severable joint for endovascular embolic devices
US6409721B1 (en)1998-02-192002-06-25Target Therapeutics, Inc.Process for forming an occlusion in a body cavity
US6168615B1 (en)1998-05-042001-01-02Micrus CorporationMethod and apparatus for occlusion and reinforcement of aneurysms
US6486266B2 (en)1998-05-112002-11-26Nisshinbo Industries, Inc.Thermosetting resin composition
US6063104A (en)1998-06-242000-05-16Target Therapeutics, Inc.Detachable, varying flexibility, aneurysm neck bridge
US6136015A (en)1998-08-252000-10-24Micrus CorporationVasoocclusive coil
US6306153B1 (en)1998-08-252001-10-23Micrus CorporationVasoocclusive coil
US7128736B1 (en)1998-09-042006-10-31Boston Scientific Scimed, Inc.Detachable aneurysm neck closure patch
US6723112B2 (en)1998-11-102004-04-20Scimed Life Systems, Inc.Bioactive three loop coil
US6296622B1 (en)1998-12-212001-10-02Micrus CorporationEndoluminal device delivery system using axially recovering shape memory material
US6835185B2 (en)1998-12-212004-12-28Micrus CorporationIntravascular device deployment mechanism incorporating mechanical detachment
US6478773B1 (en)1998-12-212002-11-12Micrus CorporationApparatus for deployment of micro-coil using a catheter
US6966892B2 (en)1998-12-212005-11-22Micrus CorporationApparatus for deployment of micro-coil using a catheter
US7255707B2 (en)1998-12-212007-08-14Micrus Endovascular CorporationIntravascular device deployment mechanism incorporating mechanical detachment
US8932317B2 (en)1999-06-022015-01-13Microvention, Inc.Intracorporeal occlusive device and method
US20150173771A1 (en)1999-06-022015-06-25Microvention, Inc.Intracorporeal Occlusive Device And Method
US6280457B1 (en)1999-06-042001-08-28Scimed Life Systems, Inc.Polymer covered vaso-occlusive devices and methods of producing such devices
US7695484B2 (en)1999-06-042010-04-13Boston Scientific Scimed, Inc.Polymer covered vaso-occlusive devices and methods of producing such devices
US6602261B2 (en)1999-10-042003-08-05Microvention, Inc.Filamentous embolic device with expansile elements
US6238403B1 (en)1999-10-042001-05-29Microvention, Inc.Filamentous embolic device with expansible elements
US6299619B1 (en)1999-10-042001-10-09Microvention, Inc.Methods for embolizing a target vascular site
US7014645B2 (en)1999-10-042006-03-21Microvention Inc.Method of manufacturing expansile filamentous embolization devices
US7323000B2 (en)1999-10-302008-01-29Dendron GmbhDevice for implanting of occlusion spirals
US8597321B2 (en)1999-10-302013-12-03Covidien LpDevice for the implantation of occlusion spirals
WO2001032085A1 (en)1999-10-302001-05-10Dendron GmbhDevice for implanting occlusion coils
US20120010648A1 (en)1999-10-302012-01-12Tyco Healthcare Group, LP, as successor in interest to Dendron GmbH, Inc.Device for the implantation of occlusion spirals
US8021416B2 (en)1999-12-102011-09-20Stryker CorporationMethods for delivering a prosthesis to a site in a body
US20140135818A1 (en)2000-02-092014-05-15DePuy Synthes Products, LLCApparatus and method for deployment of a therapeutic device using a catheter
US7198613B2 (en)2000-02-092007-04-03Micrus Endovascular CorporationApparatus for deployment of micro-coil using a catheter
US8298256B2 (en)2000-02-092012-10-30Micrus Endovascular CorporationApparatus and method for deployment of a therapeutic device using a catheter
US20140236217A1 (en)2000-02-092014-08-21Depuy Synthes Products, LlApparatus for deployment of micro-coil using a catheter
US8652163B2 (en)2000-02-092014-02-18DePuy Synthes Products, LLCApparatus and method for deployment of a therapeutic device using a catheter
US8728142B2 (en)2000-02-092014-05-20DePuy Synthes Products, LLCApparatus for deployment of micro-coil using a catheter
US6468301B1 (en)2000-03-272002-10-22Aga Medical CorporationRepositionable and recapturable vascular stent/graft
US20030176857A1 (en)2000-07-262003-09-18Lee Kyu HoAssembly for embolic treatments
US7331974B2 (en)2000-09-262008-02-19Microvention, Inc.Microcoil vaso-occlusive device with multi-axis secondary configuration
US6416373B1 (en)2000-10-122002-07-09Bombardier Motor Corporation Of AmericaOil system vent with remote oil reservoir
US20080051803A1 (en)2000-10-302008-02-28Dendron GmbhDevice for the implantation of occlusion spirals
US8048104B2 (en)2000-10-302011-11-01Dendron GmbhDevice for the implantation of occlusion spirals
US6743251B1 (en)2000-11-152004-06-01Scimed Life Systems, Inc.Implantable devices with polymeric detachment junction
US20060100602A1 (en)2001-01-262006-05-11William Cook Europe ApsEndovascular medical device with plurality of wires
US8721625B2 (en)2001-01-262014-05-13Cook Medical Technologies LlcEndovascular medical device with plurality of wires
US6905503B2 (en)2001-02-092005-06-14Concentric Medical, Inc.Methods and devices for delivering occlusion elements
DE10118017A1 (en)2001-04-102002-10-17Dendron GmbhUnit for implanting occlusion coils into body cavities or blood vessels via a catheter, comprises a safety device which contains a material with shape memory
US7238194B2 (en)2001-04-102007-07-03Dendron GmbhDevice for implanting occlusion spirals
US20040225279A1 (en)2001-06-012004-11-11Jean RaymondDetachable tip microcatheter for use of liquid embolic agents
US20140288633A1 (en)2001-07-202014-09-25Microvention, Inc.Aneurysm Treatment Device And Method Of Use
US8870909B2 (en)2001-07-202014-10-28Microvention, Inc.Aneurysm treatment device and method of use
US20150142042A1 (en)2001-07-202015-05-21Microvention, Inc.Aneurysm Treatment Device And Method Of Use
US8715312B2 (en)2001-07-202014-05-06Microvention, Inc.Aneurysm treatment device and method of use
US8562667B2 (en)2001-07-202013-10-22Microvention, Inc.Aneurysm treatment device and method of use
EP1420701A1 (en)2001-08-272004-05-26Dendron GmbHDevice for the implantation of occlusion means
US7524322B2 (en)2001-08-272009-04-28Dendron GmbhDevice for the implantation of occlusion means
US20040236344A1 (en)2001-08-272004-11-25Hermann MonstadtDevice for the implantation of occulusion means
US20050079196A1 (en)2001-11-122005-04-14Hans HenkesMedical implant
US6953473B2 (en)2001-12-202005-10-11Boston Scientific Scimed, Inc.Detachable device with electrically responsive element
US20030212426A1 (en)*2002-05-082003-11-13Olson, Stanley W.Tactical detachable anatomic containment device and therapeutic treatment system
US7485122B2 (en)2002-06-272009-02-03Boston Scientific Scimed, Inc.Integrated anchor coil in stretch-resistant vaso-occlusive coils
US20040002731A1 (en)2002-06-272004-01-01Nestor AganonAnchor assemblies in stretch-resistant vaso-occlusive coils
US7166122B2 (en)2002-06-272007-01-23Boston Scientific Scimed, Inc.Anchor assemblies in stretch-resistant vaso-occlusive coils
US7938845B2 (en)2002-06-272011-05-10Stryker CorporationAnchor assemblies in stretch-resistant vaso-occlusive coils
US7300458B2 (en)2002-07-192007-11-27Micro Therapeutics, Inc.Medical implant having a curlable matrix structure
US20140371839A1 (en)2002-07-192014-12-18Covidien LpMedical implant having a curlable matrix structure and method of use
US8632584B2 (en)2002-07-192014-01-21Dendron GmbhMedical implant having a curlable matrix structure and method of use
US20080125855A1 (en)2002-07-192008-05-29Hans HenkesMedical implant having a curlable matrix structure
EP2415424A2 (en)2002-07-192012-02-08Dendron GmbHMedical implant
EP2781196A2 (en)2002-07-192014-09-24Dendron GmbHStent with guide wire
US7169172B2 (en)2002-11-012007-01-30Counter Clockwise, Inc.Method and apparatus for caged stent delivery
US20110118768A1 (en)2003-01-072011-05-19Tri TranOcclusive cinching devices and methods of use
US8016869B2 (en)2003-03-262011-09-13Biosensors International Group, Ltd.Guidewire-less stent delivery methods
US7651513B2 (en)2003-04-032010-01-26Boston Scientific Scimed, Inc.Flexible embolic device delivery system
US8157855B2 (en)2003-12-052012-04-17Boston Scientific Scimed, Inc.Detachable segment stent
US20140163604A1 (en)2004-01-212014-06-12Covidien LpDevice for implanting electrically isolated occlusion helixes
US20100076479A1 (en)2004-01-212010-03-25Hermann MonstadtDevice for implanting electrically isolated occlusion helixes
US8480701B2 (en)2004-01-212013-07-09Dendron GmbhDevice for implanting electrically isolated occlusion helixes
US20110118777A1 (en)2004-05-212011-05-19Micro Therapeutics, Inc.Metallic coils enlaced with fibers for embolization of a body cavity
US20060036281A1 (en)2004-05-212006-02-16Micro Therapeutics, Inc.Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
US7896899B2 (en)2004-05-212011-03-01Micro Therapeutics, Inc.Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
US9050095B2 (en)2004-09-222015-06-09Covidien LpMedical implant
US20110098814A1 (en)2004-09-222011-04-28Micro Therapeutics, Inc.Medical implant
US20080319532A1 (en)2004-09-222008-12-25Ev3, Inc.Medical Implant
US7879064B2 (en)2004-09-222011-02-01Micro Therapeutics, Inc.Medical implant
US8372110B2 (en)2004-09-222013-02-12Covidien LpMedical implant
US8845676B2 (en)2004-09-222014-09-30Micro TherapeuticsMicro-spiral implantation device
US20080103585A1 (en)*2004-09-222008-05-01Dendron GmbhMicro-Spiral Implantation Device
US9055948B2 (en)2004-11-092015-06-16Stryker CorporationVaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion
US20060135986A1 (en)2004-12-222006-06-22Scimed Life Systems, Inc.Vaso-occlusive device having pivotable coupling
US7608089B2 (en)2004-12-222009-10-27Boston Scientific Scimed, Inc.Vaso-occlusive device having pivotable coupling
EP1843710A1 (en)2005-02-042007-10-17Boston Scientific LimitedVaso-occlusive devices including non-biodegradable biomaterials
US20090254111A1 (en)2005-04-282009-10-08Hermann MonstadtDevice for implanting occlusion spirals comprising an interior securing element
EP1884208A1 (en)2005-05-242008-02-06Kaneka CorporationMedical wire
US20060271097A1 (en)2005-05-312006-11-30Kamal RamzipoorElectrolytically detachable implantable devices
US8641746B2 (en)2005-05-312014-02-04J.W. Medical Systems Ltd.In situ stent formation
US8002789B2 (en)2005-05-312011-08-23Stryker CorporationStretch-resistant vaso-occlusive devices with flexible detachment junctions
US20070073334A1 (en)2005-09-292007-03-29Kamal RamzipoorCombined electrolytic and mechanical separation background
US20140142608A1 (en)2005-10-192014-05-22Pulsar Vascular, Inc.Methods and systems for endovascularly clipping and repairing lumen and tissue defects
EP1951129A2 (en)2005-10-192008-08-06Pulsar Vascular, IncorporatedMethods and systems for endovascularly clipping and repairing lumen and tissue defects
US8900285B2 (en)2005-11-022014-12-02Biosensors International Group, Ltd.Covering electrolytic restraint implant delivery systems
US8974509B2 (en)2005-11-022015-03-10Biosensors International Group, Ltd.Pass-through restraint electrolytic implant delivery systems
US8273116B2 (en)2005-11-022012-09-25Biosensors International Group, Ltd.Indirect-release electrolytic implant delivery systems
US8998926B2 (en)2006-04-062015-04-07DePuy Synthes Products, LLCHeat detachable coil
US20100030200A1 (en)2006-04-172010-02-04Micro Therapeutics, Inc.System and method for mechanically positioning intravascular implants
US8795321B2 (en)2006-04-172014-08-05Covidien LpSystem and method for mechanically positioning intravascular implants
US8864790B2 (en)2006-04-172014-10-21Covidien LpSystem and method for mechanically positioning intravascular implants
US8795320B2 (en)2006-04-172014-08-05Covidien LpSystem and method for mechanically positioning intravascular implants
US8777978B2 (en)2006-04-172014-07-15Covidien LpSystem and method for mechanically positioning intravascular implants
US8777979B2 (en)2006-04-172014-07-15Covidien LpSystem and method for mechanically positioning intravascular implants
US20080221666A1 (en)2006-12-152008-09-11Cardiomind, Inc.Stent systems
US8328860B2 (en)2007-03-132012-12-11Covidien LpImplant including a coil and a stretch-resistant member
US8801747B2 (en)2007-03-132014-08-12Covidien LpImplant, a mandrel, and a method of forming an implant
US20080228215A1 (en)2007-03-132008-09-18Micro Therapeutics, Inc.Implant including a coil and a stretch-resistant member
US20080228216A1 (en)2007-03-132008-09-18Micro Therapeutics Inc.Implant, a mandrel, and a method of forming an implant
EP2124763A2 (en)2007-03-132009-12-02Micro Therapeutics, Inc.An implant, a mandrel, and a method of forming an implant
EP2146651A2 (en)2007-03-212010-01-27Micrus Endovascular CorporationApparatus and method for deployment of a therapeutic device using a catheter
US8974513B2 (en)2007-05-182015-03-10Stryker CorporationMedical implant detachment systems and methods
US8221483B2 (en)2007-05-182012-07-17Stryker CorporationMedical implant detachment systems and methods
US20120271344A1 (en)2007-05-182012-10-25Stryker Nv Operations LimitedMedical implant detachment systems and methods
US20090143786A1 (en)2007-12-032009-06-04Boston Scientific Scimed, Inc.Implantable device with electrolytically detachable junction having multiple fine wires and method of introduction
EP2227163A1 (en)2007-12-032010-09-15Boston Scientific Scimed, Inc.Implantable device with electrolytically detachable junction having multiple fine wires
US20090227976A1 (en)*2008-03-052009-09-10Calabria Marie FMultiple biocompatible polymeric strand aneurysm embolization system and method
US20150105817A1 (en)2008-05-022015-04-16Sequent Medical Inc.Filamentary devices for treatment of vascular defects
US20150150563A1 (en)2008-05-022015-06-04Sequent Medical Inc.Filamentary devices for treatment of vascular defects
US20100023105A1 (en)2008-07-222010-01-28Micro Therapeutics, Inc.Vascular remodeling device
US20100049165A1 (en)2008-08-192010-02-25Micro Therapeutics, IncDetachable tip microcatheter
EP2334242A1 (en)2008-09-092011-06-22Boston Scientific Scimed, Inc.Composite detachment mechanisms
US20100063572A1 (en)2008-09-092010-03-11Boston Scientific Scimed, Inc.Composite detachment mechanisms
US8940011B2 (en)2008-09-092015-01-27Boston Scientific Scimed, Inc.Composite detachment mechanisms
EP2859854A1 (en)2008-09-092015-04-15Boston Scientific Scimed, Inc.Composite detachment mechanism
US8202292B2 (en)2008-10-132012-06-19Stryker CorporationVaso-occlusive coil delivery system
US20100256666A1 (en)2009-04-062010-10-07Boston Scientific Scimed, Inc.Delivery wire for occlusive device delivery system
US20100268204A1 (en)2009-04-152010-10-21Microvention, Inc.Implant Delivery System
US8398671B2 (en)2009-04-162013-03-19Stryker CorporationElectrical contact for occlusive device delivery system
US20130184743A1 (en)2009-04-162013-07-18Stryker Nv Operations LimitedElectrical contact for occlusive device delivery system
US8657870B2 (en)2009-06-262014-02-25Biosensors International Group, Ltd.Implant delivery apparatus and methods with electrolytic release
US20100331948A1 (en)2009-06-262010-12-30Cardiomind, Inc.Implant delivery apparatus and methods with electrolytic release
US8221396B2 (en)2009-08-272012-07-17Silver Bullet Therapeutics, Inc.Bone implants for the treatment of infection
US20110106128A1 (en)2009-11-022011-05-05Boston Scientific Scimed, Inc.Delivery wire assembly for occlusive device delivery system
US8992563B2 (en)2009-11-022015-03-31Boston Scientific Scimed, Inc.Delivery wire assembly for occlusive device delivery system
US20150157331A1 (en)2010-01-282015-06-11Covidien LpVascular remodeling device
US20110184453A1 (en)2010-01-282011-07-28Micro Therapeutics, Inc.Vascular remodeling device
US8926681B2 (en)2010-01-282015-01-06Covidien LpVascular remodeling device
US20130138198A1 (en)2010-05-282013-05-30Carsten AportaDevice for inserting an implant
EP2575697A1 (en)2010-05-282013-04-10Phenox GmbHDevice for inserting an implant
US20130211492A1 (en)2010-09-082013-08-15Manuel SchneiderImplant for influencing the blood flow in arteriovenous defects
US9039749B2 (en)2010-10-012015-05-26Covidien LpMethods and apparatuses for flow restoration and implanting members in the human body
US8915950B2 (en)2010-12-062014-12-23Covidien LpVascular remodeling device
US20150164665A1 (en)2010-12-062015-06-18Covidien LpVascular remodeling device
US20150005804A1 (en)2011-01-172015-01-01Nicholas FrananoExpandable body device and method of use
US20120209310A1 (en)2011-02-102012-08-16Stryker Nv Operations LimitedVaso-occlusive device delivery system
US8876863B2 (en)2011-03-022014-11-04Joe Michael EskridgeEndovascular closure device
US20140005651A1 (en)2011-03-022014-01-02Joe Michael EskridgeApparatus and method for positioning an implantable device
US20140148843A1 (en)2011-06-032014-05-29Reverse Medical CorporationEmbolic Implant and Method of Use
US8641777B2 (en)2011-06-032014-02-04Reverse Medical CorporationEmbolic implant and method of use
WO2012166804A1 (en)2011-06-032012-12-06Reverse Medical CorporationEmbolic implant and method of use
WO2013119332A2 (en)2012-02-092013-08-15Stout Medical Group, L.P.Embolic device and methods of use
EP2668914A1 (en)2012-06-012013-12-04Acandis GmbH & Co. KGImplant system
US20140039535A1 (en)2012-08-032014-02-06Tyco Healthcare Group LpDevice for implantation of medical devices
US20140277092A1 (en)2013-03-142014-09-18Stryker Nv Operations LimitedVaso-occlusive device delivery system
US20140277094A1 (en)2013-03-142014-09-18Stryker Nv Operations LimitedVaso-occlusive device delivery system
US20150057700A1 (en)2013-08-202015-02-26Stryker CorporationVaso-occlusive device delivery system
US20150066073A1 (en)2013-09-032015-03-05Jianlu MaDetachment mechanisms for implantable devices
US20150133990A1 (en)2013-11-132015-05-14Covidien LpGalvanically assisted attachment of medical devices to thrombus

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
European Search Report dated Oct. 5, 2016; European Application No. 16166685.4; 9 pages.
U.S. Appl. No. 14/454,880, filed Aug. 8, 2014.
U.S. Appl. No. 14/454,930, filed Aug. 8, 2014.
U.S. Appl. No. 14/708,688, filed May 11, 2015.

Also Published As

Publication numberPublication date
CA2927874A1 (en)2016-11-11
JP2016209574A (en)2016-12-15
CN106137294B (en)2018-08-07
JP6203327B2 (en)2017-09-27
US20160331381A1 (en)2016-11-17
KR20160132768A (en)2016-11-21
KR101788972B1 (en)2017-10-20
CA2927874C (en)2018-05-22
EP3092956B1 (en)2018-09-26
CN106137294A (en)2016-11-23
EP3092956A1 (en)2016-11-16

Similar Documents

PublicationPublication DateTitle
CA2927874C (en)Electrolytic detachment for implant delivery systems
US11839380B2 (en)Electrolytic and mechanical detachment for implant delivery systems
CA2897593C (en)Electrolytic detachment elements for implant delivery systems
EP3092957A1 (en)Electrolytic detachment with flush system for implant delivery
EP2240093B1 (en)Detachment mechanisms for implantable devices

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:COVIDIEN LP, MASSACHUSETTS

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MA, JIANLU;REEL/FRAME:037916/0161

Effective date:20150401

ASAssignment

Owner name:COVIDIEN LP, MASSACHUSETTS

Free format text:CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY STREET ADDRESS PREVIOUSLY RECORDED AT REEL: 037916 FRAME: 0161. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:MA, JIANLU;REEL/FRAME:039349/0317

Effective date:20150401

STCFInformation on status: patent grant

Free format text:PATENTED CASE

MAFPMaintenance fee payment

Free format text:PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment:4

MAFPMaintenance fee payment

Free format text:PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment:8


[8]ページ先頭

©2009-2025 Movatter.jp